Treatment of brain metastases in patients with melanoma

被引：10
作者：
Fisher, Rosalie [1 ]
Larkin, James [1 ]
机构：
[1] Royal Marsden Hosp, London SW3 6JJ, England
来源：
LANCET ONCOLOGY | 2012年 / 13卷 / 05期
关键词：
VEMURAFENIB; IPILIMUMAB;
D O I：
10.1016/S1470-2045(12)70118-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：434 / 435
页数：2
相关论文
共 9 条
[1]   Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation [J].
Chapman, Paul B. ;
Hauschild, Axel ;
Robert, Caroline ;
Haanen, John B. ;
Ascierto, Paolo ;
Larkin, James ;
Dummer, Reinhard ;
Garbe, Claus ;
Testori, Alessandro ;
Maio, Michele ;
Hogg, David ;
Lorigan, Paul ;
Lebbe, Celeste ;
Jouary, Thomas ;
Schadendorf, Dirk ;
Ribas, Antoni ;
O'Day, Steven J. ;
Sosman, Jeffrey A. ;
Kirkwood, John M. ;
Eggermont, Alexander M. M. ;
Dreno, Brigitte ;
Nolop, Keith ;
Li, Jiang ;
Nelson, Betty ;
Hou, Jeannie ;
Lee, Richard J. ;
Flaherty, Keith T. ;
McArthur, Grant A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2507-2516
[2]   An open-label pilot study of vemurafenib in previously treated metastatic melanoma patients with brain metastases. [J].
Dummer, R. ;
Rinderknecht, J. ;
Goldinger, S. M. ;
Wagner, I. ;
Mitchell, L. ;
Veronese, M. L. ;
Nick, S. ;
Hilfiker, P. ;
Gobbi, S. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[3]   Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].
Hodi, F. Stephen ;
O'Day, Steven J. ;
McDermott, David F. ;
Weber, Robert W. ;
Sosman, Jeffrey A. ;
Haanen, John B. ;
Gonzalez, Rene ;
Robert, Caroline ;
Schadendorf, Dirk ;
Hassel, Jessica C. ;
Akerley, Wallace ;
van den Eertwegh, Alfons J. M. ;
Lutzky, Jose ;
Lorigan, Paul ;
Vaubel, Julia M. ;
Linette, Gerald P. ;
Hogg, David ;
Ottensmeier, Christian H. ;
Lebbe, Celeste ;
Peschel, Christian ;
Quirt, Ian ;
Clark, Joseph I. ;
Wolchok, Jedd D. ;
Weber, Jeffrey S. ;
Tian, Jason ;
Yellin, Michael J. ;
Nichol, Geoffrey M. ;
Hoos, Axel ;
Urba, Walter J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723
[4]   Phase I/II study of GSK2118436, a selective inhibitor of oncogenic mutant BRAF kinase, in patients with metastatic melanoma and other solid tumors [J].
Kefford, R. ;
Arkenau, H. ;
Brown, M. P. ;
Millward, M. ;
Infante, J. R. ;
Long, G. V. ;
Ouellet, D. ;
Curtis, M. ;
Lebowitz, P. F. ;
Falchook, G. S. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[5]   Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial [J].
Margolin, Kim ;
Ernstoff, Marc S. ;
Hamid, Omid ;
Lawrence, Donald ;
McDermott, David ;
Puzanov, Igor ;
Wolchok, Jedd D. ;
Clark, Joseph I. ;
Sznol, Mario ;
Logan, Theodore F. ;
Richards, Jon ;
Michener, Tracy ;
Balogh, Agnes ;
Heller, Kevin N. ;
Hodi, F. Stephen .
LANCET ONCOLOGY, 2012, 13 (05) :459-465
[6]   Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma [J].
Robert, Caroline ;
Thomas, Luc ;
Bondarenko, Igor ;
O'Day, Steven ;
Weber, Jeffrey ;
Garbe, Claus ;
Lebbe, Celeste ;
Baurain, Jean-Francois ;
Testori, Alessandro ;
Grob, Jean-Jacques ;
Davidson, Neville ;
Richards, Jon ;
Maio, Michele ;
Hauschild, Axel ;
Miller, Wilson H., Jr. ;
Gascon, Pere ;
Lotem, Michal ;
Harmankaya, Kaan ;
Ibrahim, Ramy ;
Francis, Stephen ;
Chen, Tai-Tsang ;
Humphrey, Rachel ;
Hoos, Axel ;
Wolchok, Jedd D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2517-2526
[7]   Vemurafenib for Melanoma Metastases to the Brain [J].
Rochet, Nicole M. ;
Kottschade, Lisa A. ;
Markovic, Svetomir N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (25) :2439-2441
[8]   Management of Melanoma BrainMetastases in the Era of Targeted Therapy [J].
Shapiro, Daniela Gonsalves ;
Samlowski, Wolfram E. .
JOURNAL OF SKIN CANCER, 2011, 2011
[9]   Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial [J].
Weber, Jeffrey S. ;
Amin, Asim ;
Minor, David ;
Siegel, Jonathan ;
Berman, David ;
O'Day, Steven J. .
MELANOMA RESEARCH, 2011, 21 (06) :530-534
1